Looks like there gonna try to get it approved as an add on.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| AbbVie (ABBV) Falls 13% After Results for Emraclidine in Schizophrenia Did Not Meet their Primary Endpoint | 3 | 116 | November 11, 2024 | |
| AbbVie's Emraclidine: M4 Agonist Might Become Best-In-Class In Schizophrenia | 0 | 81 | October 9, 2024 | |
| AbbVie to tap Vraylar messaging lessons, but also create a new position to promote key psychiatric drug from Cerevel buy | 2 | 301 | December 8, 2023 | |
| Emraclidine delivers positive results in phase Ib trial | 0 | 188 | December 28, 2023 | |
| Cerevel says schizophrenia candidate emraclidine doesn't increase blood pressure | 12 | 535 | January 1, 2023 |